IL1B and Parkinson disease: In summary, our study unveils a novel cellular and molecular mechanism that underlies the neuroprotection of the Drd3 agonist PPX in an inflammation-related mouse model of PD, and demonstrates the suppression of astrocytic NLRP3 inflammasome and IL-1β production by PPX through an autophagy-dependent mechanism.